Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

[Progress in transcatheter aortic valve implantation].

Josep Rodés-Cabau¹

¹Instituto de Cardiología de Quebec. Universidad Laval. Québec. Canadá. josep.rodes@criucpq.ulaval.ca

Revista Espanola De Cardiologia

|March 26, 2010

Summary

Transcatheter aortic valve implantation is a safe and effective treatment for severe symptomatic aortic stenosis in high-risk patients. Early results show high success rates and low mortality, with promising hemodynamic profiles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<sup>18</sup>F-Fluorodeoxyglucose Uptake Pattern in Noninfected Transcatheter Aortic Valves.

Circulation. Cardiovascular imaging·2020

Same author

Impact of Left-Ventricular Dysfunction in Patients With High- and Low- Gradient Severe Aortic Stenosis Following Transcatheter Aortic Valve Replacement.

The Canadian journal of cardiology·2020

Same author

Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation.

JACC. Cardiovascular interventions·2020

Same author

Impact of Atrial Septal Defect Closure on Migraine Headaches: Results From a Multicenter Prospective Registry.

Circulation. Cardiovascular interventions·2020

Same author

Transcatheter Mitral Valve Replacement With the Transseptal EVOQUE System.

JACC. Cardiovascular interventions·2020

Same author

Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2020

Area of Science:

Cardiovascular Medicine
Interventional Cardiology
Biomedical Engineering

Context:

Severe symptomatic aortic stenosis poses significant risks for traditional surgical valve replacement.
Transcatheter aortic valve implantation (TAVI) emerged as a less invasive alternative.
Early single-center trials established the feasibility of TAVI in high-risk and inoperable patients.

Purpose:

To review the safety and efficacy of transcatheter aortic valve implantation (TAVI).
To assess the outcomes of TAVI in patients with severe symptomatic aortic stenosis.
To evaluate the hemodynamic performance and procedural success rates of TAVI.

Summary:

Multicenter trials demonstrate TAVI, using devices like the Edwards SAPIEN valve and CoreValve Revalving System, is safe and effective.

Related Experiment Videos

Last Updated: Jun 14, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

These trials report success rates exceeding 90% and 30-day mortality below 10% in high-risk populations.

Prosthetic valves show favorable short- and medium-term hemodynamic characteristics.

Impact:

The PARTNER study is expected to further solidify TAVI's role for inoperable or high-risk patients.
Long-term data on complications and durability are needed before TAVI can be considered for lower-risk patients.
TAVI represents a significant advancement in managing aortic valve disease, offering a viable option for previously untreatable patients.